The global hyaluronic acid market is expected to follow a bullish trend line at a consistent 6.3% CAGR through 2034. The industry is pegged at USD 9,694.6 million in 2024 and is set to secure USD 17,927 million by 2034.
Though the traditional focus on anti-aging benefits is a strong driver, the definition of beauty itself is transforming. Social media is relentless in promoting an emphasis on plump, sculpted features, which is increasing the demand for hyaluronic acid fillers well beyond their traditional use for wrinkle reduction.
Nowhere is this more evident than in Asia, where nonsurgical procedures involving hyaluronic acid for facial contouring and definition have seen tremendous growth. The new beauty standards, in turn, demand a wider range of hyaluronic acid-based products, making the producers challenged to become inventive and satisfy the growing whims of changing customers.
The new applications of hyaluronic acid go far beyond the aesthetics sector and move toward the increasingly promising "athleisure" movement. The increasing level of participation in sports and fitness activities has therefore led to a huge demand for products that would enhance joint health and mobility.
In this case, the already well-developed joint-lubricating properties of hyaluronic acid come into play. In this respect, there is bound to be a boom in hyaluronic acid supplement sales to a new type of consumer market for those who want to enhance their performance. This trend signifies a strategic shift within the market, as manufacturers cater to a segment that values functionality alongside aesthetics.
Modern consumers are increasingly discerning, demanding transparency in product ingredients and ethical sourcing practices. Hyaluronic acid obtained through sustainable methods, like vegan fermentation, represents an option that aligns with these values.
Manufacturers who place transparency in the supply chain practice and adopt ethical sourcing practices are likely to attract a higher share, more so among the young demographics that are conscious about environmental matters. This focus on responsible production answers to a growing segment that is looking for high-quality products commensurate with their ethical beliefs.
Attributes | Description |
---|---|
Estimated Global Hyaluronic Acid Market Size (2024E) | USD 9,694.6 million |
Projected Global Hyaluronic Acid Market Value (2034F) | USD 17,927 million |
Value-based CAGR (2024 to 2034) | 6.3% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Microneedling Revolution! Unlocking Hyaluronic Acid's Full Potential
Microneedling with hyaluronic acid has become an increasingly popular, non-invasive alternative for those wishing to achieve optimized results. The novel technique entails making miniature perforations in the skin with fine needles to allow deeper penetration of the product. By overcoming the skin's natural barriers, microneedling optimizes both absorptions of and the beneficial effects derived from hyaluronic acid treatments, and more dramatic improvements in skin texture and hydration can be realized.
Hyaluronic Acid Serums Offer Synergy
Hyaluronic acid is becoming non-monotherapeutic. The market expects a surge in the number of serums with the combination of hyaluronic acid and other powerful ingredients like antioxidants and peptides. This serum imparts a multi-functional treatment approach by acting on concerns such as fine lines, dull skin, and sagging, all in one. This trend is a response to the wishes of consumers wanting to have efficacy with simplicity in product use.
New Areas of Application for Topical Products
Hyaluronic acid is going needle-free to cast a wider net among consumers. New topicals formulated with enhanced delivery systems can mimic many of the benefits achieved with injectables, providing consumers with more options. These advancements encompass technologies like liposomal encapsulation, which utilizes microscopic spheres to deliver hyaluronic acid deeper into the skin's layers. This innovation caters to individuals who prefer non-invasive solutions for maintaining youthful and hydrated skin.
Hyaluronic Acid Targets a New Audience
The old-fashioned girly talk on skincare is passing as the consciousness of having proper skincare does not leave the male species behind. The market sees a growing demand for hyaluronic acid-applied products tailor-made to the special needs of male skin, which most commonly are greater sebum production, causes of razor burn, and premature aging signs. Manufacturers can tap previously under-served segments of the sector by developing targeted products that address such needs.
DIY Customization! Consumer Empowerment with Hyaluronic Acid Powder
The DIY beauty movement readily embraces hyaluronic acid. The trend of hyaluronic acid powders underlines high personalization potential in skincare routine practices at home. It can be well customized, whereby one can switch up the concentration of hyaluronic acid in the serum or mask according to exactly what it is they need. It feeds the growing desire to regain control over individual skincare regimens and aligns with the rise in popularity of DIY beauty solutions.
The global hyaluronic acid market is poised for robust growth ahead. Whereas the historical CAGR from 2019 to 2023 was a stable 4.1%, the projected CAGR for 2024 to 2034 surges to a strong 6.3%. This upward shift is indicative of the confluence of factors in reshaping the market.
One key driver is the changing consumer preference. The urge to look chiseled in the social media era is leading to a demand for non-surgical procedures much beyond the necessity of wrinkle elimination. This is true in Asia, where facial contouring and definition through hyaluronic acid fillers are gaining momentum.
As discussed above, the increasing trend of athleisure is also giving rise to new consumer groups in the hyaluronic acid supplements market. This is consistent with a trend in which athletes and fitness-conscious individuals are looking for products that will promote the health and mobility of their joints because hyaluronic acid enjoys very good lubricating attributes.
Companies that reposition their business operations to these trends and can meet varying needs across many segments of consumers could benefit from this growth. There is an expected development of topicals with advanced delivery systems.
Such advancements intend to mirror the advantages of injectable treatments, which could give more traction in the market and attract a larger consumer base preferring non-invasive solutions. This is followed by the trend of transparency and sustainability, which affects consumer choice. Ethical sourcing and ingredient transparency are the points in favor of modern consumers.
India holds key to untapped potential in hyaluronic acid sales expansion. Whereas China’s hyaluronic acid sector is set to witness rapid expansion with a CAGR of 7.1% from 2024 to 2034. In comparison, adoption of hyaluronic acid is sluggish in the United States, Germany and the United Kingdom, where the CAGR stands at 3.6%, 3%, and 2.5% respectively.
Countries | CAGR 2024 to 2034 |
---|---|
United States | 3.6% |
United Kingdom | 2.5% |
Germany | 3% |
India | 9.4% |
China | 7.1% |
The United States has long had a developed market for hyaluronic acid, and a CAGR of 36% estimated for the sector indicates a stable increase. This is because the use of these injectables and dermal fillers containing hyaluronic acid continues to be very popular.
Nevertheless, after the primary market is mature, this might be a potential risk for traditional applications. Inventions are the gateway to re-vitalizing the economy. One of the newest advancements is microneedling with hyaluronic acid, which provides a deeper product penetration for better results.
The other progress is the development of combination serums that feature hyaluronic acid combined with other potent ingredients, such as antioxidants and peptides, which add more excitement. Nevertheless, the United States market where a lot of customers have favorite brands and are used to certain routines can be a reason for a slower adoption rate of these advancements in comparison to the regions with rapidly growing sales.
The hyaluronic acid sector in the United Kingdom is forecast to expand at a moderate CAGR of 2.5% through 2034. Market maturity and a robust consumer base that is loyal to some brands may be the main reasons behind the growth. There are areas of improvement and possible solutions that are adaptable to changing consumer preferences.
The formation of cosmeceutical products including hyaluronic acid may have a future. These products are designed to address particular issues such as hyperpigmentation or uneven skin texture, hence attracting British consumers who are in the know about the science behind these solutions and who desire to target their skincare problems.
This trend specifies a chance of the launch and marketing of hyaluronic acid supplements that are formulated to meet the needs of this active segment of the United Kingdom population.
India's hyaluronic acid demand is rising with a forecast CAGR of 9.4% through 2034. This market has become very dynamic due to the increase in demand for beauty and personal care products. Unlike the developed markets which are primarily oriented towards anti-aging, India offers a unique environment in this regard.
The increasing acceptance of minimally invasive cosmetic surgeries in the country is generating a healthy demand for hyaluronic acid fillers, particularly for facial contouring and definition, which is consistent with the current beauty trends that put emphasis on sharp facial features.
This trend, which is also accompanied by a growing interest in joint health among the elderly, generates a good prospect for the Indian hyaluronic acid market to experience remarkable growth in the next few years. Apart from this, the surge of social media and its impact on beauty standards is likely to additionally stoke the demand for hyaluronic acid-based products in India.
Pharmaceutical grade hyaluronic acid will emerge as the dominant segment in 2024, commanding a substantial 52.9% market share. Dermatology clinics & cosmetic surgery centers witness a surge in demand, capturing a significant 58.1% share.
Segment | Pharmaceutical Grade (Grade) |
---|---|
Value Share (2034) | 52.9% |
Pharmaceutical grade hyaluronic acid is estimated to hold a 52.9% share in 2024. This superiority can be credited to the wide spread of hyaluronic acid in different medical areas. This involves the use of technology in ophthalmology, osteoarthritis treatment as well as wound healing. Senior population is a major trigger for the growth of this segment, particularly in developed regions.
Such a medical demand for interventions aimed at treating age-related ailments is likely to be accompanied by the use of hyaluronic acid products in such procedures. Besides that, the research in the treatment of some diseases, such as dry eye syndrome and osteoarthritis, also indicates new opportunities for the growth of this segment.
Segment | Dermatology Clinics & Cosmetic Surgery Centers (End User) |
---|---|
Value Share (2034) | 58.1% |
The dermatology clinics and cosmetic surgery centers are anticipated to constitute a share of 58.1% in 2024. This segment's growth is driven by the needs that are demanding more aesthetic procedures. hyaluronic acid fillers are a top candidate for wrinkle reduction, facial contouring, and lip augmentation.
Also, the increasing number of minimally invasive processes is a factor that increases this segment since hyaluronic acid fillers provide a safe and efficient way to achieve desired aesthetic effects. Moreover, consumers are increasingly undergoing surgical procedures. This is due to the growing influence of social media, and a preference for sculpted features, which all point to the growth of this sector.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global hyaluronic acid business is a dynamic space where established players and startups coexist in an increasingly competitive environment. In the lead, the industry titans like Allergan (USA) - the company that can be considered the dominant force in the aesthetics market.
Their portfolio is diverse and has the popular Juvederm hyaluronic acid fillers that are synonymous with the name Juvederm when it comes to wrinkle reduction and facial contouring. Another critical one is Shiseido (Japan), which excels at the development of innovative skincare products.
Shiseido is a brand that is always pushing itself to the limit by including hyaluronic acid in its advanced formulations, which is appreciated by its large number of consumers who are demanding quality anti-aging products. These long-standing players rely on their well-known brand name, extensive research and development performance, and the smooth functioning of distribution channels to remain prominent players in the market.
The established players are regularly challenged by new market entrants and niche players who are striving to make their way and carve a niche for themselves. Anika Therapeutics (USA) is just one of many companies that have started to operate in this direction. This firm has built-in a strategic positioning which enables it to take advantage of the rising popularity for hyaluronic acid-based orthopedic treatments.
Their product options are exclusively designed for people with joint pain to provide pain relief on demand. Similarly, Merz Pharmaceuticals (Germany) is going great guns with their subsidiary Merz Aesthetics. Merz Aesthetics is based on its competence in injectable treatments that it provides and that are characterized by safety and effectiveness, which leads to a return of loyal clients who demand only minor upgrades.
Industry Updates
Galderma, headquartered in Switzerland, received FDA approval for Restylane EyeLight in June 2023, addressing undereye dullness in adults 21 years and older.
Allergan Aesthetics, based in the United States, obtained US FDA approval for 'Skinvive,' a hyaluronic acid intradermal microdroplet injection, in May 2023.
Bloomage Biotech Co., headquartered in South Korea, announced in September 2023 the discovery of an enzyme degradation technology controlling the molecular size of Hyaluronic Acid (H.A.) between 400Da and 4000kDa.
In March 2023, Givaudan Active Beauty, based in Switzerland, launched PrimalHyal Hydra, a positively charged cationic hyaluronic acid. This innovative product, derived from white biotechnology, is claimed to offer twice the hydrating effects of regular H.A., suitable for rinse-off and leave-on treatments.
The hyaluronic acid industry is segmented by grade into food grade, pharmaceutical grade, and dietary grade.
By end use, the industry is categorized into the pharmaceutical industry, dermatology clinics & cosmetic surgery centers, food industry, and personal care.
Region wise segmentation includes North America, Latin America, Europe, East Asia, South Asia and Pacific, and Middle East and Africa.
The industry is estimated to reach USD 9,694.6 million in 2024.
Demand is likely to rise at a 6.3% CAGR by 2034.
The industry is set to reach USD 17,927 million in 2034.
Few prominent companies are Allergen Plc. Contipro A.S., and Symatese Group.
Pharmaceutical grade segment is estimated to lead the industry.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 6.1. Grade 6.2. End-Use 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Grade 7.1. Food Grade 7.2. Pharmaceutical Grade 7.3. Dietary Grade 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-Use 8.1. Pharmaceutical Industry 8.2. Dermatology Clinics 8.3. Cosmetic Surgery Centers 8.4. Food Industry 8.5. Personal Care 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. South Asia 9.5. East Asia 9.6. Eastern Europe 9.7. Middle East & Africa 10. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 11. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. South Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Sales Forecast 2024 to 2034 by Grade and End-Use for 30 Countries 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 19. Company Profile 19.1. Allergen Plc 19.2. Contipro A.S 19.3. Symatese Group 19.4. Zhonglan Industry Co. 19.5. Altergaon Italia Srl 19.6. Fidia Farmaceutici S.P.A 19.7. Bioiberica S.A.U 19.8. Kewpie Corporation 19.9. Seikagaku Corporation 19.10. Anika Therapeutics 19.11. Kikkoman Biochemifa Company
Explore Chemicals & Materials Insights
View Reports